Size | Price | Stock | Qty |
---|---|---|---|
100mg |
|
||
250mg |
|
||
Other Sizes |
|
ln Vitro |
At 1.2 M of L-Alanine, the viability of 201B7 cells and ehiPSCs decreases to 7.5±1.3% and 3.7±0.7%, respectively, as the concentration of L-Alanine increases. The viability of hFBs and hSkMCs, however, does not appear to have decreased. Although iCMs' vitality marginally declines as L-Alanine concentration rises, it is still considerably greater (p<0.01) than that of undifferentiated iPSCs, 201B7 cells, and ehiPSCs at 1.2 M concentration of L-Alanine (49.4±6.9%). Even after two or four hours of treatment, the vitality of 201B7 cells, hiPSCs, and ehiPSCs sharply declines. However, the viability of hFBs exhibits a slight decline at 24 hours of treatment, failing to decrease at 1, 2, and 4 hours. Following a 2-hour treatment with 1.2 M L-Alanine, the vitality of 201B7 cells in suspension culture drops to 11.8±6.0%, while that of hFBs is 72.9±14.2%[1].
|
---|---|
References | |
Additional Infomation |
L-alanine is the L-enantiomer of alanine. It has a role as an EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor and a fundamental metabolite. It is a pyruvate family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and an alanine. It is a conjugate base of a L-alaninium. It is a conjugate acid of a L-alaninate. It is an enantiomer of a D-alanine. It is a tautomer of a L-alanine zwitterion.
Alanine is a non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system. L-Alanine is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Alanine is an Amino Acid. Alanine has been reported in Euphorbia prostrata, Angelica gigas, and other organisms with data available. Alanine is a small non-essential amino acid in humans, Alanine is one of the most widely used for protein construction and is involved in the metabolism of tryptophan and vitamin pyridoxine. Alanine is an important source of energy for muscles and central nervous system, strengthens the immune system, helps in the metabolism of sugars and organic acids, and displays a cholesterol-reducing effect in animals. (NCI04) Alanine is a nonessential amino acid made in the body from the conversion of the carbohydrate pyruvate or the breakdown of DNA and the dipeptides carnosine and anserine. It is highly concentrated in muscle and is one of the most important amino acids released by muscle, functioning as a major energy source. Plasma alanine is often decreased when the BCAA (Branched Chain Amino Acids) are deficient. This finding may relate to muscle metabolism. Alanine is highly concentrated in meat products and other high-protein foods like wheat germ and cottage cheese. Alanine is an important participant as well as regulator in glucose metabolism. Alanine levels parallel blood sugar levels in both diabetes and hypoglycemia, and alanine reduces both severe hypoglycemia and the ketosis of diabetes. It is an important amino acid for lymphocyte reproduction and immunity. Alanine therapy has helped dissolve kidney stones in experimental animals. Normal alanine metabolism, like that of other amino acids, is highly dependent upon enzymes that contain vitamin B6. Alanine, like GABA, taurine and glycine, is an inhibitory neurotransmitter in the brain. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system. A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. See also: Glatiramer Acetate (monomer of); Glatiramer (monomer of); Amlisimod (monomer of) ... View More ... Drug Indication Used for protein synthesis. Mechanism of Action L-Alanine is a non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system. BCAAs are used as a source of energy for muscle cells. During prolonged exercise, BCAAs are released from skeletal muscles and their carbon backbones are used as fuel, while their nitrogen portion is used to form another amino acid, Alanine. Alanine is then converted to Glucose by the liver. This form of energy production is called the Alanine-Glucose cycle, and it plays a major role in maintaining the body's blood sugar balance. |
Molecular Formula |
C3H7NO2
|
---|---|
Molecular Weight |
89.09
|
Exact Mass |
89.047
|
CAS # |
56-41-7
|
Related CAS # |
25191-17-7
|
PubChem CID |
5950
|
Appearance |
White to off-white solid powder
|
Density |
1.2±0.1 g/cm3
|
Boiling Point |
212.9±23.0 °C at 760 mmHg
|
Melting Point |
314.5 °C (dec.)(lit.)
|
Flash Point |
82.6±22.6 °C
|
Vapour Pressure |
0.1±0.9 mmHg at 25°C
|
Index of Refraction |
1.460
|
LogP |
-0.68
|
Hydrogen Bond Donor Count |
2
|
Hydrogen Bond Acceptor Count |
3
|
Rotatable Bond Count |
1
|
Heavy Atom Count |
6
|
Complexity |
61.8
|
Defined Atom Stereocenter Count |
1
|
SMILES |
C[C@@H](C(=O)O)N
|
InChi Key |
QNAYBMKLOCPYGJ-REOHCLBHSA-N
|
InChi Code |
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1
|
Chemical Name |
(2S)-2-aminopropanoic acid
|
Synonyms |
Alanine AlaninumL-(+)-Alanine Alanina NSC-206315 NSC206315NSC 206315
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
H2O : ~150 mg/mL (~1683.69 mM)
DMSO :< 1 mg/mL |
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (561.23 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 11.2246 mL | 56.1230 mL | 112.2460 mL | |
5 mM | 2.2449 mL | 11.2246 mL | 22.4492 mL | |
10 mM | 1.1225 mL | 5.6123 mL | 11.2246 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
NCT Number | Recruitment | interventions | Conditions | Sponsor/Collaborators | Start Date | Phases |
NCT00586885 | COMPLETED | Drug: L-alanine | Nonalcoholic Steatohepatitis | Keith D Lindor, M.D. | 2004-02 | Not Applicable |
NCT01288495 | TERMINATED | Dietary Supplement: supplemental L-alanine
Dietary Supplement: Metamucil |
Dietary Fructose Intolerance | Augusta University | 2009-02 | Not Applicable |
NCT05096793 | COMPLETED | Dietary Supplement: beta alanine | Beta-alanine | University of Americas | 2021-05-03 | Not Applicable |
NCT01185210 | UNKNOWN STATUS | Dietary Supplement: Placebo Dietary Supplement: Alanine Dietary Supplement: Alanine |
Fructose Intolerance | Augusta University | 2007-09 | Not Applicable |
NCT04022434 | UNKNOWN STATUS | Dietary Supplement: Placedo Dietary Supplement: Alanine |
Fructose Intolerance | Augusta University | 2014-01-07 | Not Applicable |